Condensed Consolidated Statements of Shareholder’s Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024		87,918,147
Beginning balance at Dec. 31, 2024	$ 165,845	$ 879	$ 211,397	$ (46,013)	$ (418)
Shareholders' Equity [Roll Forward]
Net loss	(7,313)			(7,313)
Share-based compensation expense	121		121
Issuance of common stock sold in initial public offering, net of offering costs (in shares)		632,523
Issuance of common stock sold in initial public offering, net of offering costs	2,500	$ 6	2,494
Shares outstanding, ending balance (in shares) at Mar. 31, 2025		88,550,670
Ending balance at Mar. 31, 2025	161,153	$ 885	214,012	(53,326)	(418)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2024		87,918,147
Beginning balance at Dec. 31, 2024	165,845	$ 879	211,397	(46,013)	(418)
Shareholders' Equity [Roll Forward]
Net loss	(11,988)
Shares outstanding, ending balance (in shares) at Jun. 30, 2025		88,550,670
Ending balance at Jun. 30, 2025	159,099	$ 885	216,633	(58,001)	(418)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2025		88,550,670
Beginning balance at Mar. 31, 2025	161,153	$ 885	214,012	(53,326)	(418)
Shareholders' Equity [Roll Forward]
Net loss	(4,675)			(4,675)
Share-based compensation expense	121		121
Capital contributions	2,500		2,500
Shares outstanding, ending balance (in shares) at Jun. 30, 2025		88,550,670
Ending balance at Jun. 30, 2025	$ 159,099	$ 885	216,633	(58,001)	(418)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2025	129,678,789	129,678,789
Beginning balance at Dec. 31, 2025	$ 159,464	$ 1,297	221,850	(63,037)	(646)
Shareholders' Equity [Roll Forward]
Net loss	(15,132)			(15,132)
Share-based compensation expense	756		756
Issuance of common stock sold in initial public offering, net of offering costs (in shares)		8,564,729
Issuance of common stock sold in initial public offering, net of offering costs	88,700	$ 86	88,614
Shares outstanding, ending balance (in shares) at Mar. 31, 2026		138,243,518
Ending balance at Mar. 31, 2026	$ 233,788	$ 1,383	311,220	(78,169)	(646)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2025	129,678,789	129,678,789
Beginning balance at Dec. 31, 2025	$ 159,464	$ 1,297	221,850	(63,037)	(646)
Shareholders' Equity [Roll Forward]
Net loss	$ (169,103)
Shares outstanding, ending balance (in shares) at Jun. 30, 2026	172,393,518	172,393,518
Ending balance at Jun. 30, 2026	$ 827,881	$ 1,724	1,058,943	(232,140)	(646)
Shares outstanding, beginning balance (in shares) at Mar. 31, 2026		138,243,518
Beginning balance at Mar. 31, 2026	233,788	$ 1,383	311,220	(78,169)	(646)
Shareholders' Equity [Roll Forward]
Net loss	(153,971)			(153,971)
Share-based compensation expense	112,427		112,427
Issuance of common stock sold in initial public offering, net of offering costs (in shares)		34,150,000
Issuance of common stock sold in initial public offering, net of offering costs	$ 635,637	$ 341	635,296
Shares outstanding, ending balance (in shares) at Jun. 30, 2026	172,393,518	172,393,518
Ending balance at Jun. 30, 2026	$ 827,881	$ 1,724	$ 1,058,943	$ (232,140)	$ (646)